NOVO NORDISK MEXICO supplier risk profile and Q1-2026 import footprint analysis.
NOVO NORDISK MEXICO recorded 79 shipments across 3 suppliers and 3 source countries during Q1 2026. Denmark dominated the supply footprint with 61 shipments (77.2% share), primarily through parent company NOVO NORDISK. Pharmaceutical preparations (HS Chapter 30) accounted for the majority of imports, with HS code 300439 alone representing 45 shipments (57.0% of total volume). Secondary suppliers included NOVO NORDISK HEALTH CARE (Switzerland, 12 shipments) and Q SQUARED SOLUTIONS (United States, 6 shipments).
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
No sanctions watchlist hits were recorded for NOVO NORDISK MEXICO in Q1 2026. The importer registered zero suppliers with forced-labor exposure flagged under UFLPA proximity screening.
3 distinct tier-1 suppliers in Q1 2026
| NOVO NORDISK | Denmark | 61 |
| NOVO NORDISK HEALTH CARE | Switzerland | 12 |
| Q SQUARED SOLUTIONS | United States | 6 |
Share of Q1 2026 inbound shipments by source country
38 tier-2 + 169 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.